260 related articles for article (PubMed ID: 3728534)
1. Prevalence and mechanisms of aminoglycoside resistance. A ten-year study.
Phillips I; King A; Shannon K
Am J Med; 1986 Jun; 80(6B):48-55. PubMed ID: 3728534
[TBL] [Abstract][Full Text] [Related]
2. Aminoglycoside resistance among blood culture isolates.
Huovinen P; Grönroos P; Herva E; Katila ML; Klossner ML; Renkonen OV; Toivanen P
J Clin Microbiol; 1984 Jul; 20(1):65-9. PubMed ID: 6378968
[TBL] [Abstract][Full Text] [Related]
3. Review of epidemic aminoglycoside resistance worldwide.
Mayer KH
Am J Med; 1986 Jun; 80(6B):56-64. PubMed ID: 3089005
[TBL] [Abstract][Full Text] [Related]
4. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
Schassan HH
Infection; 1976; 4(2):35-41. PubMed ID: 789246
[TBL] [Abstract][Full Text] [Related]
5. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.
Ruiz-Palacios GM; Ponce de Leon S; Sifuentes J; Ponce de Leon S; Calva JJ; Huazano F; Ontiveros C; Ojeda F; Bobadilla M
Am J Med; 1986 Jun; 80(6B):71-5. PubMed ID: 3089006
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
Knothe H
J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
Watanakunakorn C; Kauffman CA
Infection; 1978; 6(3):111-5. PubMed ID: 98451
[TBL] [Abstract][Full Text] [Related]
8. In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics.
Kabins SA; Nathan C; Cohen S
Antimicrob Agents Chemother; 1976 Jul; 10(1):139-45. PubMed ID: 825021
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
Yourassowsky E; Schoutens E; Vanderlinden MP
Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.
Meyer RD; Draus LL; Pasieczinik KA
Antimicrob Agents Chemother; 1976 Oct; 10(4):677-81. PubMed ID: 825036
[TBL] [Abstract][Full Text] [Related]
11. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
Jotzoff M
Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of aminoglycoside resistance. European data.
Van Landuyt HW; Boelaert J; Glibert B; Gordts B; Verbruggen AM
Am J Med; 1986 Jun; 80(6B):76-81. PubMed ID: 3089007
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
Saavedra S; Vera D; Ramírez-Ronda CH
Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
[No Abstract] [Full Text] [Related]
16. In vitro study of netilmicin compared with other aminoglycosides.
Fu KP; Neu HC
Antimicrob Agents Chemother; 1976 Sep; 10(3):526-34. PubMed ID: 10829
[TBL] [Abstract][Full Text] [Related]
17. Acquired cross resistance to aminoglycosides in gentamicin-sensitive and gentamicin-resistant strains of enterobacteria.
Al-Asadi MJ; Towner K; Greenwood D
J Med Microbiol; 1981 May; 14(2):171-83. PubMed ID: 7014903
[TBL] [Abstract][Full Text] [Related]
18. Aminoglycoside resistance mechanisms in Enterobacteriaceae and Pseudomonas spp. from two Danish hospitals: correlation with type of aminoglycoside used.
Busch-Sørensen C; Sönmezoglu M; Frimodt-Møller N; Højbjerg T; Miller GH; Espersen F
APMIS; 1996 Oct; 104(10):763-8. PubMed ID: 8980628
[TBL] [Abstract][Full Text] [Related]
19. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
Bovelacci A; Montini G; Ramacciotti PG
Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of gentamicin resistance in nosocomial infections.
John JF; Rubens CE; Farrar WE
Am J Med Sci; 1980; 279(1):25-30. PubMed ID: 6768292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]